Clinical Trial: Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris - A Randomized, Double Blind, Placebo Controlled, Multice

Brief Summary:

Low intensity shockwaves have been proven in animal and pilot clinical studies to induce local growth of new blood vessels. Small single-center clinical trials with shockwave therapy showed promising results in reducing angina symptoms, improving perfusion and contractility in patients with refractory angina and stress-induced ischemia on imaging test.

The hypothesis of this study is that shockwave therapy could improve angina symptoms and exercise tolerance in broader population of patients with stable angina regardless of imaging test results Study aims to demonstrate anti-anginal efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy (ESMR), on top of stable optimal medical treatment in patients with stable angina.


Detailed Summary:

Low intensity shockwaves (0.09 millijoule/mm2) are delivered to myocardial tissue. Shockwaves are created by a special generator and are focused using a shockwave applicator device. The treatment is guided by standard echocardiography equipment. The shockwaves are delivered in synchronization with Patient R-wave (ECG) to avoid arrhythmias. The treatment is painless.

At first, the patient undergoes modified Bruce treadmill test, to assess exercise induced ischemia.

Exercise induced ECG ischemia is defined as the new development of horizontal or down - sloping ST segment depression (≥1 mm at 60 ms after J point) versus baseline tracing.

Study treatment consists of 9 sessions, with 3 sessions per week 1, 5 and 9. 100 shocks are delivered per spot, 1200 shocks per session.

During 1st treatment week ESMR will be delivered 3 times (every other day) to basal segments (2 spots in each wall in apical 4-, 2-, 3- chamber positions).

During 2nd treatment week ESMR will be delivered 3 times (every other day) to middle segments (2 spots in each wall in apical 4-, 2-, 3- chamber positions).

During 3rd treatment week ESMR will be delivered 3 times (every other day) to apical segments (2 spots in each wall in apical 4-, 2-, 3- chamber positions).

The spots are localized by the ultra-sound device and the shockwaves are focused to this area. Several treatments are required for optimal results.


Sponsor: Evgeny Shkolnik, MD

Current Primary Outcome: Change in Total Exercise duration [ Time Frame: 6 months ]

To evaluate if ESMR able to improve total exercise duration in modified Bruce treadmill test.

Patients will be assessed at baseline visit (screening) and 6 months after the first treatment.



Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Time to 1 mm ST-segment depression in modified Bruce treadmill test [ Time Frame: 6 months ]
  • Time to angina in modified Bruce treadmill test [ Time Frame: 6 months ]
  • Number of angina attacks per week [ Time Frame: 6 months ]
  • Number of sublingual nitroglycerin consumption per week [ Time Frame: 6 months ]
  • CCS angina functional class [ Time Frame: 6 months ]
  • Seattle angina questionnaire score [ Time Frame: 6 months ]


Original Secondary Outcome: Same as current

Information By: Moscow State University of Medicine and Dentistry

Dates:
Date Received: January 12, 2015
Date Started: May 2012
Date Completion: September 2016
Last Updated: March 14, 2016
Last Verified: March 2016